Tag Archives: Partnership
Munich, Germany – May 12, 2025 – Smart Reporting GmbH, a global leader in AI-powered diagnostic reporting, today announced a strategic partnership with Bialogics Analytics Inc., a provider of real-time clinical and operational analytics. This collaboration enhances Smart Reporting’s analytics capabilities—helping clinicians, departments, and health systems measure, optimize, and trust the performance of AI tools directly within radiology workflows.
Together, the companies are creating a more connected and intelligent future for radiology, where adaptive reporting and real-time data insights work together to enhance clinical decision-making and AI transparency.
This collaboration brings together two complementary technologies to address one of radiology’s biggest opportunities: integrating actionable data directly into clinical workflows. By combining Smart Reporting’s innovative, adaptive, template-based reporting platform with Bialogic’s advanced analytics capabilities, the partnership delivers a seamless way for radiology departments, hospitals, and AI developers to access immediate insights and continuously monitor the effectiveness of AI tools at the point of care.
“The partnership with Bialogics relates to two fundamental beliefs: We see AI as an intelligent assistant that amplifies judgment in routine reporting. At the very same time, AI must be safe, transparent with built-in guardrails, ensuring reliability and compliance with global standards,” said Christian Matzen, COO of Smart Reporting. “With Bialogics’ Artificial Intelligence Quality ( AIQ) Framework , we provide reliable transparency for the future deployment of AI in radiology reporting – both from a clinical and operational perspective.”
Smart Reporting’s adaptive reporting solution ensures accurate, consistent documentation that streamlines workflows and reduces administrative burden, helping to ease radiologist burnout. With real-time clinical insights built into the reporting process, clinicians can make faster, more informed decisions. When combined with Bialogic’s Artificial Intelligence Quality ( AIQ) Framework , this integrated approach strengthens trust, supports compliance, and promotes responsible use of AI in clinical care.
“We believe that innovation is strongest when it’s grounded in real-world value,” said Jeff Vachon, President of Bialogics. “Working with Smart Reporting, we’re aligning adaptive reporting and analytics in a practical, scalable, and meaningful way for clinicians and institutions alike.”
This partnership represents a thoughtful step forward—one that brings together two forward-thinking solutions to deliver smarter workflows, better data, and more confident decision-making across the radiology landscape
About Smart Reporting GmbH
Smart Reporting is a global leader in adaptive reporting for radiology, pathology, and other medical specialties. Its cloud-based platform supports real-time, standardized, and multilingual report creation, helping healthcare providers improve efficiency, consistency, and data quality. Learn more at www.smart-reporting.com.
About Bialogics Analytics Inc.
Bialogics provides a real-time, vendor-neutral analytics platform designed to extract, analyze, and visualize clinical and operational data across radiology and imaging systems. Its AIQ Framework enables institutions to evaluate the performance of AI tools in real clinical environments, delivering trusted insights that support better outcomes.
Bialogics strengthens the Mach7 Enterprise Imaging Solution by enabling healthcare providers to leverage their imaging data with a robust analytics toolset.
SOUTH BURLINGTON, Vt., March 15, 2022 /PRNewswire/ — Mach7 Technologies, a company specializing in innovative medical imaging and data management solutions for healthcare providers, today announced its partnership with Bialogics Analytics Inc. Bialogics is a company that provides interoperable and innovative data analytics solutions to healthcare providers and industry vendors.
The partnership gives Mach7 customers access to world-class analytics that provide key insights across the healthcare enterprise. This will help users measure and improve patient outcomes, gain insight into operational costs for diagnostic imaging, drive greater efficiencies, manage patient follow-up exams, and support clinical research.
“This is a synergistic alignment addressing the industry’s need for increased understanding of how advanced data analysis can improve workflow, productivity, and greater efficiencies,” stated Jeff Vachon, President of Bialogics. “Providing customers with access to unprecedented levels of intelligence holds the potential to drive evidence-based improvements in imaging workflow efficiency and care quality, helping to support clinical research initiatives that aid the advancement of disease tracking and management.”
Mr. Vachon further stated the partnership between Mach7 and Bialogics would help customers support business intelligence (BI), artificial intelligence (AI), and machine learning initiatives by allowing them to leverage the imaging metadata and diagnostic reports stored within their vendor-neutral archive (VNA).
Mike Lampron, CEO of Mach7, said, “Healthcare organizations across the country are striving for greater efficiency and cost containment while still providing patients with timely, accurate, and high-quality care. The first step to achieving this is gaining an understanding of where improvements can be made. Bialogics has an innovative and interoperable analytics toolset that will mesh seamlessly with Mach7’s Enterprise Imaging Solution to provide that understanding.”
Further, Mr. Lampron stated, “We have a number of customers who use Mach7 to consolidate and manage imaging data from multiple departments across their enterprise. Giving them access to analytics and the tools to derive insights from their data will prove invaluable to refining and streamlining their workflows and operational processes. For this reason, the addition of the Bialogics solution to Mach7’s Enterprise Imaging Solution will provide truly differentiated value to our customers.”
About Mach7 Technologies:
Mach7 Technologies (ASX:M7T), founded in 2007, is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organizations. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing, and Departmental Workflow applications. Mach7’s Enterprise Data Management solution, consisting of a powerful Vendor Neutral Archive (VNA) and data administration tools, allows for the fast storage, access, retrieval, and viewing of images across a healthcare network with connectivity to the Cloud. In July 2020, Mach7 acquired Client Outlook and the eUnity Enterprise Diagnostic Viewing technology to augment Mach7’s Enterprise Data Management and Departmental Workflow applications. eUnity is a zero-footprint, FDA-approved, image viewing solution that makes images accessible on any workstation. This offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. Uniquely, the company also gives customers independence to deploy its solutions either on a component basis or in a unified comprehensive platform. With more than 150 customers across 15 different countries, Mach7 has built a global network of diverse customers that range from expansive Integrated Delivery Networks, National Health Systems, medical research facilities, and large academic medical institutions to regional community hospitals, private radiology practices, and independent provider groups. Visit Mach7t.com.
About Bialogics:
Bialogics provides fully interoperable and innovative data transformation solutions for healthcare provider organizations and industry vendors that enable informed business decisions, greater workflow efficiencies, and improved patient outcomes. Developed in collaboration with industry partners and healthcare clients Bialogics vendor agnostic platform for Medical Imaging, incorporates data sources across the imaging chain to enable a vendor agnostic analytics tool-set to measure and improve patient outcomes, diagnostic imaging operational costs and efficiencies, patient follow up exam management and clinical research. The pursuit of our vision has resulted in a unique platform designed to support Business Intelligence, Quality Assurance, AI, and Machine Learning applications. – simple, cost-effective, and powerful.
Toronto, ON. and Vancouver, BC., October 16, 2019 – Bialogics Analytics Inc. and emtelligent™ have signed a Memorandum of Understanding to integrate Bialogics DImax AI Ready Business Intelligence Platform with emtelligent’s emtelliPro™ Natural Language Processing engine. Using emtelliPro to extract structured clinical data from imaging reports, Bialogics will be able to provide radiology departments with richer, deeper, analytics-based insights that maximize both operational efficiencies and clinical effectiveness.
“We’re excited to partner with a proven vendor like Bialogics whose powerful tech is complementary to our own,” said Dr. Tim O’Connell, CEO of emtelligent. “As a practicing radiologist, I fully appreciate the value that Bialogics brings to radiology departments, and our combined offering delivers completely new ways to improve departmental capability.”
Jeff Vachon, President of Bialogics adds: “Today’s imaging departments need access to crossfunctional patient data from all corners of the healthcare organization. The convergence of imaging data with knowledge extracted from patient reports by emtelligent provides a new level of business and clinical intelligence.”
Bialogics’ DImax AI Ready Business Intelligence Platform is completely vendor agnostic and fully interoperable. Bialogics’ engine captures data flowing from multiple information silos in all protocols including but not limited to DICOM, HL7 and XML (FHIR-ready). The engine then normalizes these inputs into executable information and exportable data, enabling in depth analysis of the entire radiology process through drill-down tables and graphics, including user configurable dashboards and scheduled reporting. The implementation process requires no complex interfaces or expensive integrations to capture accurate data from RIS/PACS/ADT/EHR and other CIS systems.
emtelligent’s emtelliPro solution is a highly scalable, highly-accurate clinical natural language processing platform that extracts structured data from the unstructured text of medical documents like the radiology reports that flow through Bialogics’ BI platform. Through structuring this data, Bialogics will be able to provide completely new insights into radiology department operations that have the potential to inform management, cost, and care decisions.
About Bialogics Analytics
Based in Toronto, ON, Bialogics’ AI-Ready Business Intelligence (BI) Platform has been developed in collaboration with healthcare clients and business partners to provide fully interoperable and innovative data transformation and analysis solutions that supports the emerging data management needs of Artificial Intelligence (AI) and Machine Learning (ML) technologies. Bialogics platform for Medical Imaging Administrators and Physicians, incorporates a comprehensive toolset to measure and improve access to diagnostic imaging data, providing in depth analysis of procedural appropriateness, performance management, and operational cost and efficiencies. For more information please visit: www.bialogics.com, and info@bialogics.com
About emtelligent
Based in Vancouver, BC, emtelligent partners with healthcare institutions, companies and organizations to strategically structure their unstructured medical data, helping them increase safety, operating efficiency and the quality of care. The emtelliPro engine and emtelliSuite™ tailored applications are available now, and the team is on-hand to consult regarding your medical data needs. Learn more or schedule a demonstration at www.emtelligent.com or call 1-877-GO-EMTEL (1-877-463-6835) today.
Bialogics Contact: Andrew Vachon avachon@bialogics.com (647-234-2659)
emtelligent Contact: Greg Rutherford, grutherford@emtelligent.com (416-268-2558)
Bialogics Analytics and Paragon Consulting Partners partner to provide an integrated Business Intelligence Workflow Assessment Program
Collaboration Combines the Power of Bialogics’ Business Intelligence Analytics with Decades of Clinical Workflow and Data Analysis Expertise from Paragon Consulting Partners to Realize New Value from Medical Imaging Data
Toronto, Ontario, CA and Sacramento, California, USA – May 28, 2019 – Bialogics Analytics, Inc. and Paragon Consulting Partners, LLC (PCP Imaging) are pleased to announce a new program that combines Bialogics’ advanced diagnostic imaging data analytics platform with PCP Imaging’s clinical workflow and data analysis expertise to allow hospitals and health networks to extract actionable clinical, operational, and financial insights for achieving peak organizational efficiency from across RIS, EMR, Radiology, and Cardiovascular systems.
Together they provide a Business Intelligence (BI) Assessment Program that includes current-state clinical workflow and data assessments, development of key performance indicators (KPIs) for benchmarking and measuring strategic initiatives, and design of real-time dashboards and reports to inform value-based and continuous improvement initiatives. In partnering together, Bialogics and PCP Imaging can now offer their clients access to highly efficient and fully interoperable data mining and analysis tools driven by clinical, technical, and operational experts with decades of hands-on experience in enterprise imaging data management and optimization.
“This is a synergistic alignment addressing the industry’s need for increased understanding of how advanced data analysis can improve workflow, productivity, and greater efficiencies, turning data into a valuable asset for BI, AI, and Machine learning in the future,” said Jeff Vachon, President of Bialogics.
“Now more than ever healthcare organizations of all sizes and profiles are amassing data at an incredible rate. However, because this information is typically spread across multiple systems and locations they are limited in their ability to efficiently access and inspect data in a way that truly facilitates the extraction of timely and meaningful insights,” said Jef Williams, PCP Imaging’s Managing Partner. “Through this partnership, we will be able to help our clients design and execute BI programs that will enable them to achieve their strategic objectives through data-driven performance tracking and decision making.”
Bialogics and PCP Imaging look forward to working together to help healthcare organizations realize new value from their data and to further industry knowledge and best practices on how Business Intelligence can be leveraged to improve efficiency and quality across imaging workflows, specialties, departments, and facilities.
About Bialogics Analytics
Bialogics’ AI-Ready Business Intelligence (BI) Platform has been developed in collaboration with healthcare clients and business partners to provide fully interoperable and innovative data transformation and analysis solutions that supports the emerging data management needs of Artificial Intelligence (AI) and Machine Learning (ML) technologies. We set out to build a true vendor agnostic platform for Medical Imaging Administrators and Physicians, incorporating a comprehensive tool-set to measure and improve access to diagnostic imaging, procedural appropriateness performance management, and operational cost and efficiencies. The pursuit of our vision has resulted in a unique data engine designed to support BI, AI, and ML applications – simple, cost-effective, and powerful. For more information please visit: www.bialogics.com, and follow us on LinkedIn and Twitter.
About Paragon Consulting Partners
Paragon Consulting Partners, LLC brings decades of healthcare IT and medical imaging expertise. Serving luminary health systems, hospitals, and independent practices across the United States and Canada, PCP Imaging has become a trusted partner in clinical workflow optimization and health data management and analysis initiatives. Our approach to strategy development and project delivery blends deep clinical, technical, and operational subject matter expertise, quality, and even some fun in collaborating with our clients and partners to achieve their enterprise data management goals.
In support of our vision to unify and improve the healthcare delivery model, we give back to the industry and community by participating as members across a number of industry associations, working groups, and academic boards including AHRA, IHE, HIMSS-SIIM, RBMA, NIHI Canada, and more.
For more information about Paragon Consulting Partners, please visit: www.pcpimaging.com, and follow us on LinkedIn, Twitter, and Facebook.
For more information contact;
Andrew Vachon
Director, Client Services
avachon@bialogics.com
Jef Williams
Managing Partner
Newton, Mass. and Toronto, Ontario – May 21, 2019 – Life Image, the world’s largest global network for sharing clinical and imaging data that is powered by industry leading interoperability standards, and Bialogics Analytics, a leading provider of business intelligence analytics, today announced they have formed a strategic partnership that will streamline access to analytics of medical imaging in order to help provider organizations enhance operational and financial performance, and improve patient satisfaction.
Based in Toronto, Bialogics is a Canadian company who shares a similar mission with Life Image to eliminate data silos and democratize data through interoperability using common standards. Developed over eight years with industry partners and healthcare clients, Bialogics’ analytical platform is a vendor-agnostic analytical platform for medical imaging that is easily integrated into existing hospital systems. Through this partnership, the Bialogics analytical tool is being offered to Life Image’s large global network of hospital and health systems to help organizations gather data from mission-critical clinical systems isolated within hospitals, physician practices, and regional infrastructures. Data that is typically locked up in individual applications include admissions, discharge, transfer, order entry, pharmacy, laboratory, digital imaging, and medical records.
“Without question, the way imaging data has been collected and managed has advanced significantly. This data represents a treasure trove of information that is of significant strategic value that, until recently, has been untapped due to structure, format, and interoperability challenges,” said Jeff Vachon, President, Bialogics. “Through this partnership, Life Image customers can use the Bialogics data engine to capture data flowing from common standards such as DICOM, HL7, XML, and FHIR. Implementation does not require complex interfaces or integrations, saving time and resources with an immediate ROI. Users can perform analysis from their desktop without the need to request and wait months for IT-driven reports.”
As a result of the partnership, Life Image customers are able to analyze their entire operation, including image management, procedure management, practice management, and in-depth workflow analysis. Healthcare organizations, in turn, can use the information to be more efficient and effective in providing care to patients. For example, providers can optimize procedure times to increase overall efficiency, improve scheduling and productivity, decrease patient wait time and length of office stay, expedite patient treatment plans, increase utilization of modality assets, and, potentially, increase throughput and billing revenue.
“There is a growing emphasis across healthcare on prescriptive analytics, as more users want to be able to embed analytics into key processes and patient care management systems. This trend is driving both Life Image and Bialogics to continue pursuing our shared mission: democratizing data and improving interoperability,” said Matthew Michela, President, and CEO, Life Image. “Partnering with Bialogics is an effective way for us to leverage the power of the Life Image network and infuse it with Bialogics’ market-leading analytics tools to help organizations improve their clinical and operational workflows and deliver the highest quality care possible.”
About Bialogics Analytics
Bialogics Analytics provides fully interoperable and innovative data transformation solutions for healthcare providers and industry partners that support the data management requirements for the emerging markets of AI, ML and Business Intelligence. Bialogics AI-Ready, Business Intelligence Platform, has been developed in collaboration with healthcare clients and business partners, we set out to build a true vendor agnostic platform for Medical Imaging Administrators and Physicians, incorporating a comprehensive tool-set to measure and improve patient access to diagnostic imaging, procedural appropriateness performance management, and operational cost and efficiencies. The pursuit of our vision has resulted in a unique data engine designed to support business intelligence, AI, and Machine Learning applications – simple, cost-effective, and powerful. For more information please visit: www.bialogics.com
About Life Image
With its beginnings in medical image exchange, Life Image now orchestrates the flow of any and all clinical information across the patient’s journey, in real time, to help care teams and researchers make informed decisions. Founded in 2008, Life Image has spent the past decade innovating and building an interoperable network ecosystem connecting hospitals, physicians, patients, pharmaceuticals, medical device, telehealth, and EHRs. Today, the Life Image network connects over 1,500 facilities in the United States and 8,000 affiliated sites, including 8 of the top 10 U.S. hospitals, with 150,000 U.S. providers and 58,000 clinics globally.
For more information about Life Image, please visit: www.lifeimage.com, and check out our blog and follow us on Twitter, Facebook, and LinkedIn.
Media Contacts
Ashley Owen
Aria Marketing for Life Image
aowen@ariamarketing.com
617-332-9999, x 216
Andrew Vachon
Director of Client Services, Bialogics Analytics
avachon@bialogics.com
647-234-2659
August 8, 2018
Toronto, Ontario, August 8/2018- Bialogics has announced that Peterborough Regional Health Centre (PRHC) will be implementing its DImax Analytics solution as its Business Intelligence Platform for Diagnostic Imaging. The project also will also include the implementation of DoseMonitoring by PACSHealth for patient radiation dose monitoring.
The Bialogics DImax Radiology Analytics solution is being implemented in order to improve the efficiency of PRHC’s Diagnostic department by providing operational performance and patient workflow-based business intelligence analytics all in real time. As a state‐of‐the‐art data management tool, DImax securely and efficiently gathers data from mission‐critical clinical systems. This immediate access delivers an instant impact on operational performance, workflow analysis, and patient care. Additionally, the PACSHealth DoseMonitor solution will provide immediate enterprise-wide visibility into radiation dose exposure across multiple modalities, improving safety for patients.
“Having ready access to this data will improve our performance by decreasing wait times as well as reducing report turnaround times, ultimately enabling us to provide better, safer care for our patients,” said Lorel Morrison, Director of Diagnostic Imaging, Laboratory and Pharmacy at PRHC.
“We are pleased to be chosen by PRHC as a partner on this innovative project. It’s always exciting to work with organizations like PRHC who understand how data can be leveraged to improve their patient care,” said Jeff Vachon, CEO of Bialogics.
About Peterborough Regional Health Centre (PRHC)
Peterborough Regional Health Centre (PRHC) Located in Peterborough, Ontario, PHRC has 2400 staff, 370 physicians and 600 volunteers serving a population of 300,000 people in Peterborough and the surrounding region. With a capacity of 494 beds, PRHC has one of the busiest Emergency Departments in Ontario and offers an extensive range of services, including specialized programs in renal, stroke, cardiac, cancer care and vascular surgery.
About Bialogics
Bialogics is a Canadian company which provides innovative data transformation to the healthcare setting, enabling informed business decisions, greater efficiency, and improved patient outcomes. We believe that by unlocking data already available on your health network, intelligent insight can be delivered to any user from a single source, where and when the information is needed – simple, cost-effective and powerful. For more information visit our company at www.bialogics.com
TORONTO, July 19, 2018 – Bialogics Analytics announces today that it has been accepted into the MaRS Health venture services program. Bialogics brings its deep understanding of the operational and performance processes of diagnostic imaging systems, with the ability to collect, structure and present data into insightful information.
MaRS Health connects small- to mid-sized companies like Bialogics with the capital, customers and talent they need to grow, and also offers a range of expert mentorship and advisory services. MaRS will help Bialogics with further product development, technology partnerships and expansion into international markets.
While working with MaRS, Bialogics will look to develop a new take on the DI ecosystem, where data can be pulled across multiple silos, provide deeper insight through data utilization and continue to develop its innovative AI Ready Business Intelligence platform for analytics, dashboard reporting, and Machine Learning capabilities
About MaRS MaRS Discovery District (@MaRSDD) in Toronto is North America’s largest urban innovation hubs. Our purpose is to help innovators change the world. MaRS supports promising ventures tackling key challenges in the health, cleantech, fintech, and enterprise sectors as they start, grow and scale. In addition, the MaRS community fosters cross-disciplinary collaboration to drive breakthrough discoveries and new solutions to be adopted in Canada and beyond, growing our economy and delivering societal impact at scale.
